Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
about
The microRNA feedback regulation of p63 in cancer progressionRegulation of p63 protein stability via ubiquitin-proteasome pathway.Phosphorylation of ΔNp63α via a novel TGFβ/ALK5 signaling mechanism mediates the anti-clonogenic effects of TGFβ.Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer.Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasisISG15 regulates IFN-γ immunity in human mycobacterial diseaseUsp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification.Emerging roles for immunomodulatory functions of free ISG15.Interferon-Stimulated Gene 15 in the Control of Cellular Responses to Genotoxic Stress.ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway.Reading, writing, and repair: the role of ubiquitin and the ubiquitin-like proteins in DNA damage signaling and repair.Mechanism of Dose-Dependent Regulation of UBE1L by Polyphenols in Human Bronchial Epithelial Cells.Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation.ISGylation - a key to lock the cell gates for preventing the spread of threats.Cell type-dependent regulation of free ISG15 levels and ISGylation.ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair.Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.Inflammatory interferon activates HIF-1α-mediated epithelial-to-mesenchymal transition via PI3K/AKT/mTOR pathway.
P2860
Q28084646-C825FAF1-7D1D-472A-9753-90156D84439DQ33562444-EF26AB40-C28B-4DE5-B529-48248C6C8097Q34482997-F1CF1E4A-3D29-48FA-94E0-B0050E99942FQ35675264-B6F3DB4E-FBFF-4652-94B8-43199102C8A0Q35903273-7FCCEA13-A070-46B6-8FFB-1B0130688FE4Q36596725-32681B5F-A8EC-4B79-9CF7-EAF0A2788A73Q37040823-5DA61E01-4471-40AD-AEAF-023D91C667E2Q37201724-20AE3976-83C7-4A02-B378-CC294CB21070Q37404247-46E531D9-B818-4B5A-A90F-6E08E5B7E77DQ37683519-BB2555B2-B6E3-469B-919C-E25CD16E09D4Q37687572-1213D3AD-2407-4700-B801-67DF0F99D1FAQ37688501-EF7ACF1F-F31A-4C9D-9975-6DF47BC99872Q38095917-62EE3BEB-1DE4-4B93-86BC-153246FE1FA7Q38913252-8DA41C7E-B94F-461B-8B1A-C63580BC7A8AQ39228289-074B8776-73EC-4C15-A6AC-172178985B6AQ40079195-7877859D-8E0E-4C8B-AD39-E8ECCE8D37DDQ41865133-378DBCE4-94FA-467F-8CCB-8E760CED09BBQ47138566-A79FA683-5F9A-421A-9F43-77387F961CD8Q49787255-F6719A67-9DB8-4E09-BEAC-83A4B2839394Q51731135-CDCFDA2E-EECC-4B38-87DA-64065992E123
P2860
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@ast
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@en
type
label
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@ast
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@en
prefLabel
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@ast
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@en
P2093
P2860
P356
P1476
Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
@en
P2093
Chin Ha Chung
Hee Min Yoo
Jae Hong Seol
Jung-Mi Park
Kyu Hee Oh
Mi Gyeong Jo
Se-Hoon Hong
Seung Hyeun Ka
Yong Keun Jung
Young Joo Jeon
P2860
P304
P356
10.1172/JCI61762
P407
P577
2012-06-18T00:00:00Z